Related Experiment Video

Updated: Aug 19, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

[Pediatric oncology: unity of science and clinic]

L A Durnov1, I V Bondar'

  • 1NII of Pediatric Oncology ONTs RAMN, Moscow.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|January 1, 1996
PubMed

Insights

Pediatric oncology in Russia has advanced over 30 years, noting unique challenges in childhood cancers. Aggressive, congenital tumors and developmental factors significantly impact pediatric cancer presentation and outcomes.

Area of Science:

  • Oncology
  • Pediatrics
  • Developmental Biology

Context:

  • Review of 30 years of pediatric oncology progress in Russia.
  • Highlights differences in childhood cancer presentation and course.
  • Addresses the unique anatomical and physiological aspects of pediatric patients.

Purpose:

  • To outline advancements in pediatric oncology over three decades.
  • To discuss the specific characteristics of childhood malignant neoplasms.
  • To explore the etiology of congenital tumors in children.

Summary:

  • Pediatric cancers exhibit distinct clinical courses due to developmental factors and a higher prevalence of aggressive, high-grade tumors (sarcomas, germinogenic tumors).
  • Most childhood tumors are congenital, influenced by maternal and fetal exogenous/endogenous factors.
  • These factors can lead to fetal death, developmental malformations, or a combination, impacting neoplastic processes.

Impact:

  • Provides insights into the evolution of pediatric cancer care in Russia.
  • Emphasizes the importance of considering developmental biology in pediatric oncology.
  • Contributes to understanding the origins and presentation of congenital pediatric neoplasms.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...